Evidence map›Paper›PMID 41803091›Full record

ArticleCell death & disease2026

HIF2α-induced lysyl oxidase safeguards successful pregnancy by remodelling collagens at the feto-maternal interface.

Shizu Aikawa, Ryoko Shimizu-Hirota, Akihiko Sakashita, Xueting He, Daiki Hiratsuka, Chihiro Ishizawa, Rei Iida, Yamato Fukui, Takehiro Hiraoka, Mitsunori Matsuo and 4 more

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Shizu AikawaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7407-4051
Ryoko Shimizu-HirotaDepartment of Internal Medicine, Center for Preventive Medicine, Keio University School of Medicine, Tokyo, Japan.
Akihiko SakashitaDevelopmental Genome Plasticity Research Team, RIKEN BioResource Research Center, Tsukuba, Ibaraki, Japan.
Xueting HeDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0009-0003-6101-5046
Daiki HiratsukaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7128-2859
Chihiro IshizawaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Rei IidaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yamato FukuiDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Takehiro HiraokaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Mitsunori MatsuoDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Norihiko TakedaDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Masahito IkawaResearch Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.ORCID http://orcid.org/0000-0001-9859-6217
Yutaka OsugaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yasushi HirotaDepartment of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. hirotay-gyn@h.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0003-0241-9780

Funding

Astellas Foundation for Research on Metabolic Disorders N/AInoue Foundation for Science N/AJapan Agency for Medical Research and Development (AMED) JP24gn0110069Japan Agency for Medical Research and Development (AMED) JP24lk0310083Japan Agency for Medical Research and Development (AMED) JP25gk0210039Japan Agency for Medical Research and Development (AMED) JP25gk0210042Japan Agency for Medical Research and Development (AMED) JP25gk0210045Japan Agency for Medical Research and Development (AMED) JP25gn0110085Japan Agency for Medical Research and Development (AMED) JP25gn0110097MEXT | Japan Science and Technology Agency (JST) JPMJFR210HMEXT | Japan Society for the Promotion of Science (JSPS) 19K16022MEXT | Japan Society for the Promotion of Science (JSPS) 23K08278MEXT | Japan Society for the Promotion of Science (JSPS) 23K27176MEXT | Japan Society for the Promotion of Science (JSPS) 24K21911MEXT | Japan Society for the Promotion of Science (JSPS) 24K22157MEXT | Japan Society for the Promotion of Science (JSPS) 25H01065MEXT | Japan Society for the Promotion of Science (JSPS) 25K02779Naito Foundation N/AUehara Memorial Foundation N/A
6 · The paper itself

Abstract

During the initial stage of gestation, precise constructions of the microenvironment at the feto-maternal interface are critical for successful embryonic development to term. It consists of the fetal placenta and the maternal decidua, contributing to favorable pregnancy outcomes and long-term health in both mother and child. Remarkably, although our previous work demonstrated that physiological uterine hypoxia promotes blastocyst implantation into the decidua basalis and onset of trophoblastic invasion via the hypoxia-inducible factor (Hif) signaling pathway, it remains unclear which key regulatory cascades are triggered underlying. Here, we harnessed recent advances of the spatial transcriptomic technology in combination with genetic mouse models to gain a more comprehensive understanding of physiological uterine hypoxia. We revealed that hypoxia-induced remodeling of the extracellular matrices (ECMs) allows the blastocyst-derived trophoblastic cells to invade into the uterine stroma upon implantation. Mechanistically, Hif2α drives the expression of lysyl oxidase (Lox) that crosslinks collagen I fibrils and their stabilization in the vicinity of the attached embryos. Uterine-specific knockout (uKO) of Hif2α and Lox compromised the process of embryo invasion, leading to female infertility. Collectively, our findings provide mechanistic insight into how hypoxia governs early embryonic invasion and contributes to successful pregnancy.

Indexed as

Basic Helix-Loop-Helix ProteinsCollagenProtein-Lysine 6-OxidaseAnimalsEmbryo ImplantationEndothelial PAS Domain-Containing Protein 1Extracellular MatrixFemaleHumansMiceMice, KnockoutPlacentaPregnancyTrophoblastsUterusBasic Helix-Loop-Helix ProteinsCollagenEndothelial PAS Domain-Containing Protein 1Protein-Lysine 6-Oxidase

Identifiers

PMID41803091
PMCPMC12972092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.